Schedule 13D ownership disclosure

Odonate Therapeutics, Inc.

Security class unavailable · CUSIP: 676079106

Event date: 2017-12-06

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,085,687
Percent of class
11.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001214659-17-007344
Form type
SC 13D
Filer
Odonate Holdings, LLC
CIK
CIK 1724078
Filed
Dec 18, 2017
Reporting period
Dec 06, 2017
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub